Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL581013 | 1.00 | ALOX15 (0.41) | ALOX15TDP1TSHRALDH1A1CA1 | |
| SCHEMBL19585963 | 0.86 | ACHE (0.36) | ALOX15TDP1TSHRALDH1A1CA1 | |
| SCHEMBL18789227 | 0.86 | ALDH1A1 (0.65) | ALOX15TDP1TSHRALDH1A1CA1 | |
| SCHEMBL855199 | 0.86 | TSHR (0.41) | ALOX15TDP1TSHRALDH1A1L3MBTL1 | |
| SCHEMBL7483193 | 0.86 | ALOX15 (0.32) | ALOX15TDP1TSHRALDH1A1 | |
| SCHEMBL855012 | 0.86 | ALDH1A1 (0.41) | ALOX15TDP1TSHRALDH1A1TYMS | |
| SCHEMBL23914626 | 0.83 | CA1 (0.31) | CA1CA2CA7CA9 | |
| SCHEMBL19585504 | 0.82 | AR (0.36) | F7F3 | |
| SCHEMBL29411884 | 0.78 | ALOX15 (0.50) | ALOX15TDP1CA1CA2CA7 | |
| SCHEMBL263099 | 0.78 | ALOX15 (0.50) | ALOX15TDP1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116867942-B | Method for preparing lignocellulose and reinforced composite material thereof | 浙江大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118638459-A | Waterproof and wear-resistant raincoat applique material and preparation method thereof | 玉山县美斯旅游用品有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-115926397-B | Method for preparing degradable nanocellulose reinforced composite material | 浙江大学 | 2024-08-27 | — | — | CN | claimed |
| CN-115819630-B | Method for preparing high-charge nanocellulose | 浙江大学衢州研究院 | 2024-07-05 | — | — | CN | claimed |
| CN-116867942-A | Method for preparing lignocellulose and reinforced composite material thereof | 浙江大学 | 2023-10-10 | — | — | CN | claimed |
| CN-116367672-A | Preparation method of perovskite device | 宣城先进光伏技术有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-115926397-A | Method for preparing degradable nanocellulose reinforced composite materials | 浙江大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115819630-A | Method for preparing high-charge-capacity nanocellulose | 浙江大学衢州研究院 | 2023-03-21 | — | — | CN | claimed |
| CN-115606033-A | Electrochemical device and electronic device comprising same | 宁德新能源科技有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114085224-A | Preparation method of pyrrolopyrimidine compound | 北京普祺医药科技有限公司 | 2022-02-25 | — | — | CN | claimed |
| US-20250092468-A1 | BIOMARKERS OF RESPONSE TO HIF-2-ALPHA INHIBITION IN CANCER AND METHODS FOR THE USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-03-20 | — | — | US | disclosed |
| US-12234516-B2 | Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-02-25 | — | — | US | disclosed |
| CN-119264119-A | Preparation method and application of FLT3 degradation agent based on pyrazinecarboxamide skeleton | 中国科学院上海有机化学研究所 | 2025-01-07 | — | — | CN | disclosed |
| CN-116867942-B | Method for preparing lignocellulose and reinforced composite material thereof | 浙江大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-119137113-A | THR beta analogues and uses thereof | 马德里加尔制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-109867661-B | Amide compounds for regulating WNT signal pathway and application thereof | 中国医学科学院药物研究所 | 2022-07-19 | — | — | CN | disclosed |
| CN-110325531-B | Benzenesulfonamides and their use as therapeutic agents | 泽农医药公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114442431-A | Photosensitive resin composition containing polyimide precursor | 上海玟昕科技有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114415472-A | Photosensitive resin composition containing polyimide precursor | 上海玟昕科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114085224-A | Preparation method of pyrrolopyrimidine compound | 北京普祺医药科技有限公司 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12234516-B2 | Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof | HIF1AN, HIF1A, EGLN2 | ALOX15 3735/4885TDP1 3395/4885TSHR 2547/4885 |
| US-20250092468-A1 | BIOMARKERS OF RESPONSE TO HIF-2-ALPHA INHIBITION IN CANCER AND METHODS FOR THE USE THEREOF | HIF1AN, HIF1A, EGLN2 | ALOX15 3735/4885TDP1 3395/4885TSHR 2547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.